Unilife has developed Unifill EZMix multiple-chamber ready-to-fill (prefilled) safety syringe for lyophilized drugs and vaccines requiring reconstitution.Unifill EZMix syringes comprises two or more drug containers within a single glass barrel to store a combination of liquid stable or lyophilized drugs along with up to 1mL of diluent for reconstitution. The end-user before swirling the device to complete reconstitution, can advance the plunger to mix the lyophilized powder with the diluent.The Unifill EZMix syringe is available with either a fixed (staked) needle for drugs indicated for subcutaneous injections, or with attachable needles of up to 1.5 inches in length.
Unilife CEO Alan Shortall said Unifill EZMix syringes are designed to address the unmet needs of pharmaceutical and biotechnology companies active within the large market for lyophilized drugs and vaccines.”Pharmaceutical companies recognize that convenient devices can help enhance therapy compliance, improve patient care and generate powerful brand differentiation within competitive therapeutic classes, therefore enabling them to increase market share and revenue,”Shortall said .The company is also patenting for Unifill EZMix syringes.
